Hydroxychloroquine Sulfate Prescribing Trends and Pharmacist-Led Outbreak Preparedness in Long-Term Care Pharmacy during Coronavirus Disease 2019
The acute respiratory disease, Coronavirus disease 2019 (COVID-19), caused by the novel Coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a worldwide pandemic affecting millions of people.1,2 Residents of long-term care (LTC) settings have been severely impacted by the current COVID-19 outbreak.3 Hospitalization rates in COVID-19 positive LTC residents are over 50%, and case fatality rates are over 30%.4 Limitations in effective infection control and prevention and staff members working in multiple facilities have been found to be associated with intra- and interfacility spread.
Source: Journal of the American Medical Directors Association - Category: Health Management Authors: William R. Mills, Stephen M. Creasy, Susan Sender, Joseph Lichtefeld, Nicholas Romano, Karen Reynolds, Melissa Price, Jennifer Phipps, Leigh White, Shauen Howard Tags: Letter to the Editor Source Type: research
More News: Coronavirus | COVID-19 | Health Management | Hydroxychloroquine | Outbreaks | Pandemics | Respiratory Medicine | SARS